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Hospital-acquired infections (HAIs) are a significant problem 
globally, and a greater burden in the developing world than in more 
developed regions.[1] Addressing the problem of HAIs requires an 
understanding and appreciation of the extent of the problem, a key 
benefit of performing surveillance.
Surveillance of HAIs is the cornerstone of any infection prevention 
and control (IPC) programme. A well-co-ordinated and effective 
surveillance system should prevent a significant proportion of HAIs 
from occurring and support construction and implementation of 
further IPC efforts. These concepts were established more than 30 
years ago in the SENIC project (a study on the efficacy of nosocomial 
infection control)[2] and have been reaffirmed by more recent studies.[3]
Surveillance of HAIs in South Africa (SA) is neglected and poorly 
resourced. The true burden of HAIs is unknown, although it is largely 
accepted that it is greater in the public sector than in the private 
sector, and probably somewhere in the region of 10 - 20%.[4] However, 
a figure of 10 - 20% provides a very limited perspective on HAIs, 
and if we are to use the scarce resources at our disposal efficiently, 
more detailed analyses and reporting of HAI rates are required. A 
systematic review of HAIs in developing countries over the years 
1995 - 2008 revealed only 13 studies from Africa, none of them from 
SA.[1] The lack of data from SA is an indictment of our healthcare 
system and raises serious concerns.
Firstly, SA has no national standardised surveillance system for 
HAIs. A recently published document (under the auspices of the Global 
Antibiotic Resistance Partnership) provides a situational analysis of the 
current IPC challenges in the country.[5] In the public sector, surveillance 
activities are sorely lacking owing to understaffing and lack of training. 
Similarly, in the private sector, human resources dedicated to surveillance 
activities are often insufficient. The majority of surveillance activities 
in both the public and private sectors are laboratory based, which is 
not ideally suited to the hospital environment. The Centers for Disease 
Control and Prevention (CDC) in Atlanta, USA, have developed 
standardised definitions for HAIs that are generally accepted as the 
global standard.[6,7] Many of these definitions are clinically based, not 
requiring a culture result, and therefore necessitate clinical assessment of 
patients. In SA these definitions are generally accepted as the standard in 
both the private and public sectors, despite the lack of staff and training 
to implement these definitions in a comprehensive manner.
Objective
To report on the establishment and results of an active surveillance 
system in the setting of a private academic teaching hospital. It 
serves as a first report, based on an internationally accepted standard 
surveillance system, of device-associated HAI rates in SA and as a 
starting point to address some of the abovementioned deficiencies in 
surveillance of HAIs in this country. Furthermore, the impact of and 
challenges associated with implementing such a surveillance system 
in the context of the SA private healthcare setting are described.
Methods
The Wits Donald Gordon Medical Centre (WDGMC) is a specialist 
referral, private academic teaching hospital in Johannesburg, SA. This 
194-bed facility serves as a referral centre for transplant, oncology 
(adult and paediatric), colorectal and hepatobiliary patients. It also 
caters for orthopaedic, neurosurgical, vascular, general medical and 
a large subset of geriatric patients. In 2009, a strategy to initiate a 
fully fledged clinically based surveillance system was developed. This 
system, largely based on the National Healthcare Safety Network 
(NHSN) in the USA, was first introduced in 2010 in the intensive 
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care unit (ICU). Implementation and refinement with subsequent 
expansion to other units in the hospital took place over a 2-year 
period (2010 and 2011), with data only being analysed following 
successful implementation. During this time the hospital underwent 
extensive renovation with subsequent rearrangements of units and 
wards. The hospital currently has a 29-bed ICU/high-care unit, a 
34-bed surgical ward, a 24-bed adult oncology unit, including a 
4-bed high-care area, a 17-bed medical ward, a 24-bed hepatorenal/
transplant ward, a 42-bed mixed ward and a 16-bed paediatric 
oncology ward (these will be referred to as units A - H, although not 
necessarily in that order). Unit-specific surveillance was undertaken.
Device-associated infections (DAIs), including catheter-associated 
urinary tract infections (CAUTIs), central line-associated bloodstream 
infections (CLABSIs) and ventilator-associated pneumonias (VAPs), 
were initially targeted for surveillance. At initiation only one or two 
types of DAI per unit were selected for surveillance, based on need 
perceived by the IPC team and medical staff in the unit. Unit managers 
and other designated permanent staff in each individual ward/unit 
were trained to use the standardised surveillance definitions as 
defined by the CDC.[7] Denominator data were collected by trained 
unit staff on a daily basis using a standardised denominator data 
collection tool. Final decisions regarding an HAI were made and 
its categorisation done by the IPC team, which included a trained 
infection prevention specialist and clinical microbiologist.
During the implementation phase, weekly surveillance/audit 
rounds were conducted by the IPC team to monitor aspects of the 
surveillance programme including verification, correct application of 
surveillance definitions and collection of denominator data. Errors 
and potential challenges in conducting surveillance were identified 
through analysis of the collected data (outliers and inconsistencies). 
These were then discussed with staff to determine the underlying 
reasons for discrepancies, with subsequent implementation of 
corrective actions, extra training and support.
Data collection in each unit commenced on completion of training 
in a DAI-specific module. Data analysis only commenced after 
a period of assessment (as per weekly audits) when the unit was 
deemed to be compliant with data collection and application of 
surveillance definitions.
The data were subsequently used to guide specific interventions 
in wards where a problem was identified. This principally involved 
evaluation of device-associated ‘bundles’ with a combination of bundle 
component assessment, retraining of nursing staff and monitoring of 
compliance. The ‘bundle’ approach followed the principles of the 
‘Best Care…Always!’ initiative, a quality improvement campaign 
established in 2009 (www.bestcare.org.za).
Data analysis
The DAI surveillance data were analysed using outcome measures as 
defined by the NHSN/CDC.[7] The primary outcome measures were 
rates of infection per 1 000 device days, calculated for each month 
as follows:
DAI rate = No. infections/Total device days × 1 000.
Device utilisation (DU) ratios were calculated each month as follows:
DU ratio = No. device days/Total patient days.
Cumulative annual rates for DAIs were determined as above by 
adding the numerator and denominator data for the 12 months of 
the calendar year. The cumulative rate therefore represents a mean 
for the year. The annual mean rates were assessed statistically, 
with determination of 95% confidence intervals (CIs). Comparative 
assessment of annual mean rates for CLABSIs was done using the 
standardised infection ratio (SIR).[8] In the absence of national data 
from which to derive a benchmark SIR, the CDC NHSN 2012 and 
2013 data (for major teaching medical/surgical ICUs) were used as 
a standard.[9,10] For VAP a non-parametric comparison of means (for 
2012 v. 2014) using the Wilcoxon rank sum test was utilised, with 
p≤0.5 considered statistically significant.
Results are presented graphically as follows. DAI and cumulative 
rates are displayed as number of infections per 1 000 device days on 
the left-sided y-axis, and utilisation ratios on the right-sided y-axis. 
The mean cumulative rate for each year is reported (represented by 
the dotted grey line) and sets the benchmark for the following year.
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Fig. 1. ICU VAP rates and ventilator usage ratios for the years 2012 (A), 
2013 (B) and 2014 (C).
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The relationship between DU ratios and 
CAUTI rates across different wards was 
assessed using linear regression (GraphPad 
software).
Selected facility-wide and unit-specific 
surveillance results for the period 1 January 
2012 - 31 December 2014 are presented.
Results
DAI rates
Fig. 1 (A - C) illustrates the VAP rate for 
the ICU for the period 2012 - 2014. A 
42% reduction in the mean VAP rate from 
2012 (11.29/1 000 ventilator days; 95% CI 
1.17 - 24.58) to 2014 (6.53/1 000 ventilator 
days; 95% CI –0.19 - 13.04) is demonstrated 
(p=0.76).
Fig. 2 (A - C) illustrates the CLABSI rates 
for the ICU for the period 2012 - 2014. It 
highlights a marked reduction, with achieve-
ment of a zero rate for 23 consecutive months, 
representing a decrease in cumulative rates 
from 2.15 in 2012 (95% CI 0.41 - 3.78) to 0.0 
in 2014 (95% CI 0.0 - 0.0). The SIRs for 2012 
and 2013 were 0.48 and 0.11, respectively. 
The central line utilisation ratio increased 
from 0.52 in 2012 to 0.67 for the years 2013 
and 2014.
Fig. 3 illustrates the 2014 CAUTI rates for 
all the units in the hospital (A - H). The 
data represented highlight the importance 
of unit-specific surveillance data, where 
noticeably different targets are achieved and 
catheter utilisation ratios vary considerably. 
There was a non-significant relationship 
between DU ratios and DAI rates (p=0.81).
Discussion
We report on the establishment of a hospital-
wide, unit-specific surveillance system, to 
our knowledge the first of its kind reported 
in SA. The intention was to establish robust 
baseline data from which to reduce the 
cumulative rate on an annual basis.
Comparisons of the ICU DAI rates with 
pub lished data from both developed and 
developing countries are positive. The mean 
cumulative ICU CAUTI rate for 2014 (Fig. 3, 
A) was 1.28/1 000 catheter days. This rate 
compares favourably with CAUTI rates for 
ICU patients in developed countries (range 
2.0 - 5.3) and far surpasses those in developing 
countries (range 6.6 - 17.2). [1] Similarly, 
the mean cumulative VAP rate (6.53/1 000 
ventilator days) for 2014 (Fig.  1, C) is far 
superior to those in developing countries 
(range 19.8 - 48.0) and seemingly on a par 
with those in developed countries (2.9 - 8.0).[1] 
The mean cumulative VAP rate of 11.29/1 000 
ventilator days for 2012 (Fig. 1, A) compares 
favourably with that reported from a single 
centre in Turkey for the same year (24.04). 
However, the Turkish unit was a 55-bed ICU 
catering for a variety of patients (including 
neurosurgical patients, who typically have 
higher VAP rates), whereas our ICU is 
principally a surgical/medical one, so the 
two cannot be directly compared.[11] For 
CLABSIs, using the recognised standard for 
risk adjusting and comparing HAI rates, we 
demonstrated a SIR of <1 for all 3 years. A 
SIR of <1 indicates that fewer infections were 
observed than expected, and this coupled 
with the sustained decrease in annual rates is 
a positive indicator of quality in care.
The reduction in ICU DAI cumulative 
rates can possibly be attributed to a focused 
and sustained implementation of infection 
prevention bundles. The CLABSI bundle 
was reviewed in the middle of 2012 and 
a sustained intervention of training and 
implementation, corroborated by improved 
compliance, resulted in achievement of a zero 
rate within a few months. The surveillance 
data clearly illustrate the impact of these 
interventions and provide a basis upon 
which to systematically monitor existing and 
future interventions. However, it is difficult 
to statistically quantify the impact of these 
interventions on rates. The VAP rate, despite 
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Fig. 2. The ICU CLABSI rate and central line usage ratio for the years 2012 (A), 2013 (B) and 2014 (C). 
(CVC = central venous catheter.)
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showing a dramatic decrease, was not statistically significant. This 
probably relates to the difficulty in statistically evaluating HAI rates, 
where adjusting for risk is particularly problematic.[8] For this reason, 
SIRs are employed by the CDC to monitor progress in reduction of 
Fig. 3. The CAUTI rate and urinary catheter usage ratios for all units (A - H) for the year 2014.
CAUTI rate/1 000 urinary catheter days Urinary catheter usage ratio2014 cumulative CAUTI rate
Jan
Month
Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
30
25
20
15
10
5
0
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
A. Unit A
CA
U
TI
 ra
te
/1
 0
00
 u
ri
na
ry
 c
at
he
te
r d
ay
s
U
ri
na
ry
 c
at
he
te
r u
sa
ge
 ra
tio
CAUTI rate/1 000 urinary catheter days
Urinary catheter usage ratio
2014 cumulative CAUTI rate
Jan
Month
Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
30
25
20
15
10
5
0
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
B. Unit B
CA
U
TI
 ra
te
/1
 0
00
 u
ri
na
ry
 c
at
he
te
r d
ay
s
U
ri
na
ry
 c
at
he
te
r u
sa
ge
 ra
tio
CAUTI rate/1 000 urinary catheter days Urinary catheter usage ratio2014 cumulative CAUTI rate
Jan
Month
Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
30
25
20
15
10
5
0
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
A. Unit A
CA
U
TI
 ra
te
/1
 0
00
 u
ri
na
ry
 c
at
he
te
r d
ay
s
U
ri
na
ry
 c
at
he
te
r u
sa
ge
 ra
tio
Jan
Month
Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
30
25
20
15
10
5
0
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
C. Unit C
CA
U
TI
 ra
te
/1
 0
00
 u
ri
na
ry
 c
at
he
te
r d
ay
s
U
ri
na
ry
 c
at
he
te
r u
sa
ge
 ra
tio
Jan
Month
Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
30
25
20
15
10
5
0
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
D. Unit D
CA
U
TI
 ra
te
/1
 0
00
 u
ri
na
ry
 c
at
he
te
r d
ay
s
U
ri
na
ry
 c
at
he
te
r u
sa
ge
 ra
tio
30
25
20
15
10
5
0
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
F. Unit F
CA
U
TI
 ra
te
/1
 0
00
 u
ri
na
ry
 c
at
he
te
r d
ay
s
U
ri
na
ry
 c
at
he
te
r u
sa
ge
 ra
tio
Jan
Month
Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
30
25
20
15
10
5
0
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
E. Unit E
CA
U
TI
 ra
te
/1
 0
00
 u
ri
na
ry
 c
at
he
te
r d
ay
s
U
ri
na
ry
 c
at
he
te
r u
sa
ge
 ra
tio
Month
30
25
20
15
10
5
0
1
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
G. Unit G
CA
U
TI
 ra
te
/1
 0
00
 u
rin
ar
y 
ca
th
et
er
 d
ay
s
U
rin
ar
y 
ca
th
et
er
 u
sa
ge
 ra
tio
Jan
Month
Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
0.9
30
25
20
15
10
5
0
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
H. Unit H
CA
UT
I r
at
e/
1 
00
0 
ur
in
ar
y 
ca
th
et
er
 d
ay
s
Ur
in
ar
y 
ca
th
et
er
 u
sa
ge
 ra
tio
Jan
Month
Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
493       May 2016, Vol. 106, No. 5
RESEARCH
HAIs and to guide efforts in intensifying interventions. Calculation 
of SIRs requires a robust surveillance system to allow for comparable 
observed v. predicted infections at national, regional and local levels. 
The lack of comparative CDC data meant that we were unable to 
determine a SIR for VAP.
A hospital is very complex environment, and each hospital is unique. 
In fact, each ward within a hospital has its own unique HAI profile based 
on the discipline and the patient profile associated with that discipline. 
The 2014 CAUTI data demonstrate this, with rates varying considerably 
between wards (range 0 - 3.73/1 000 catheter days) despite an aggregate 
(hospital) rate of 1.29/1 000 catheter days (95% CI 0.29 - 2.29). The 
non-significant relationship between catheter usage ratios and CAUTI 
rates indicates that infection rates are independent of catheter usage. 
This suggests that patient-specific factors may play an important role, 
although individual ward compliance with bundles and IPC measures 
are possibly inconsistent and may be a confounder. It is therefore 
imperative to monitor compliance of interventions in conjunction 
with surveillance data analysis. The requirement for stratification by 
ward/patient profile is further highlighted by the CDC classification of 
surgical site infections (SSIs), where the risk of SSI is deemed highest 
in patients undergoing colorectal or transplant surgery and among the 
lowest in orthopaedic and obstetric surgery. The value of unit-specific 
data has also been demonstrated in terms of microbiological profiles and 
formulation of unit-specific antibiograms.[12] Unit-specific and targeted 
surveillance allows for more directed use of resources coupled with a 
more specific (by ward, discipline, patient type) measurable impact.
There were a number of challenges in establishing this system. The 
surveillance system was established over a significant period of time 
(6 years), and the fruits thereof are only now being realised. In most 
instances the introduction of the surveillance system (per unit) took 
more than a year before data collection became sufficiently reliable to 
analyse. The CDC surveillance definitions change on a yearly basis, 
complicating standardisation in defining HAIs, which necessitates 
a dedicated IPC specialist with experience in using the definitions. 
Clinical liaison is essential, as patients with HAIs on clinical grounds 
go undetected if there is no positive microbiological culture, or if no 
culture is submitted. Handling of the data is time consuming and 
currently counters real-time analysis thereof. An additional challenge 
is dissemination of the surveillance data, which is a crucial aspect if 
the data are to guide interventions. Consistent training, follow-up, 
analysis feedback and dissemination of data are critical components 
to any surveillance system, and sustainability of the HAI surveillance 
system is reliant on adequate resource allocation.
The system has grown tremendously in the past 2 years, and current 
surveillance activities per unit include: (i) at least four different HAIs 
per unit; (ii) antimicrobial use (in defined daily doses) per unit; 
and (iii) six different multidrug-resistant organisms per unit. The 
information generated by such a system can assist in understanding 
HAIs and provide guidance on the most appropriate utilisation of 
resources. As the surveillance system developed, it became apparent 
that surveillance for certain DAIs was unnecessary in certain units. 
This was based on low DU ratios with subsequent zero infection 
rates for certain units (Fig. 3). This is largely attributable to the 
patient profile of the individual units, and similarly other HAIs were 
considered more relevant with subsequent introduction of replacement 
HAI surveillance. Additionally, as the data became more robust and 
analysable, trends were followed, and based on further investigation of 
these trends interventions and/or modifications of practice were made.
A hospital surveillance system is not a stand-alone entity and 
requires significant investment in IPC, both from a management 
and an operational perspective. A recent systematic review by 
Zingg et al.[13] has highlighted the complex and multifaceted nature 
of effectively organising and implementing IPC programmes. Ten 
components were identified and graded according to quality of 
evidence, ease of implementation and applicability to the European 
Union. Interestingly, not one component scored a ‘high’ grade for any 
of the aforementioned criteria, although prospective surveillance, 
together with staff-to-occupancy ratios and hand hygiene, scored the 
highest (intermediate level) across all three criteria.[13]
Conclusions
We have shown that a surveillance system has contributed signi-
ficantly towards a proactive rather than reactive IPC approach, with 
a resultant decrease in infection rates. Targeted interventions are 
implemented based on reliable and accurate data. However, for the 
system to become truly revolutionary, it is necessary to interpret data 
over the immediate to short term and to identify a particular problem 
before it escalates. This would circumvent the traditional reactionary 
response to outbreaks and IPC interventions. Statistical process 
control may be a potential solution, and we aim to assess its value. 
Ultimately, unless we understand the burden of HAIs there is little 
we can do about them, and currently very few SA healthcare facilities 
understand their own HAI burden at a sufficiently detailed level. This 
study is a first step towards creating an awareness of the need for 
more such data. We firmly believe that our system has contributed 
significantly to the quality of patient care and provided a sound basis 
from which to reduce the burden of HAIs in the future.
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